← Back to headlines
Citizens Maintains Positive Outlook on Opus Genetics Based on Viatris Partnership
Analysts reiterated their favorable stock rating for Opus Genetics, citing strong potential value creation from its ongoing commercial partnership with pharmaceutical giant Viatris.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Prediction Platform Kalshi Bans Former Congressman George Santos for Life
31m ago
U.S. Treasury Yields Surge as Fed Official Signals Support for Rate Hike
1h ago
Dell Stock Gains Investor Focus Ahead of September Earnings Report
1h ago
Sony and Warner Music Sue Anthropic Over AI Training Copyright Claims
1h ago